STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8
Clinical trials for STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a Two-Drug punch before surgery beat head and neck cancer?
Disease control Recruiting nowThis study tests whether giving two immunotherapy drugs (cemiplimab and CDX-1140) before surgery works better than one drug alone for people with stage III-IV head and neck cancer. About 44 participants will receive either the combo or just cemiplimab before their tumor is remove…
Matched conditions: STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:11 UTC
-
New combo therapy before surgery may boost cancer fight in head and neck patients
Disease control Recruiting nowThis study is for people with head and neck cancer that has come back or not gone away. It tests if adding chemotherapy or a chemo-immunotherapy combination before standard salvage surgery can improve outcomes. About 180 participants will receive either chemo or chemo-immunothera…
Matched conditions: STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
New drug combo aims to boost radiation therapy for head and neck cancer
Disease control Recruiting nowThis early-phase trial tests whether adding the experimental drug ipatasertib to standard chemotherapy and radiation is safe for people with advanced head and neck cancer. Ipatasertib may help stop cancer cells from growing. About 46 adults with certain types of head and neck can…
Matched conditions: STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
Can adding chemo to radiation stop head and neck cancer from coming back?
Disease control Recruiting nowThis study compares two treatments for people with stage III-IVA head and neck cancer who have already had surgery to remove their tumor. One group gets radiation therapy alone, and the other gets radiation plus the chemotherapy drug cisplatin. The goal is to see which approach b…
Matched conditions: STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New drug aims to ease painful mouth sores for head and neck cancer patients
Symptom relief Recruiting nowThis study tests if adding BMX-001 to standard care can reduce severe mouth sores caused by chemoradiation in head and neck cancer patients. About 98 adults will receive either BMX-001 or a placebo alongside their usual treatment. The goal is to see if BMX-001 helps prevent painf…
Matched conditions: STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC